ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated.
If you have any questions, please contact Marianne Reed at mreed@ku.edu .
Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis
dc.contributor.author | Frankowski, Kevin J. | |
dc.contributor.author | Patnaik, Samarjit | |
dc.contributor.author | Wang, Chen | |
dc.contributor.author | Southall, Noel | |
dc.contributor.author | Dutta, Dipannita | |
dc.contributor.author | De, Soumita | |
dc.contributor.author | Li, Dandan | |
dc.contributor.author | Dextras, Christopher | |
dc.contributor.author | Lin, Yi-Han | |
dc.contributor.author | Bryant-Connah, Marthe | |
dc.contributor.author | Davis, Danielle | |
dc.contributor.author | Wang, Feijun | |
dc.contributor.author | Wachsmuth, Leah M. | |
dc.contributor.author | Shah, Pranav | |
dc.contributor.author | Williams, Jordan | |
dc.contributor.author | Kabir, Md | |
dc.contributor.author | Zhu, Edward | |
dc.contributor.author | Baljinnyam, Bolormaa | |
dc.contributor.author | Wang, Amy | |
dc.contributor.author | Xu, Xin | |
dc.contributor.author | Norton, John | |
dc.contributor.author | Ferrer, Marc | |
dc.contributor.author | Titus, Steve | |
dc.contributor.author | Simeonov, Anton | |
dc.contributor.author | Zheng, Wei | |
dc.contributor.author | Griner, Lesley A. Mathews | |
dc.contributor.author | Jadhav, Ajit | |
dc.contributor.author | Aubé, Jeffrey | |
dc.contributor.author | Henderson, Mark J. | |
dc.contributor.author | Rudloff, Udo | |
dc.contributor.author | Schoenen, Frank J. | |
dc.contributor.author | Huang, Sui | |
dc.contributor.author | Marugan, Juan J. | |
dc.date.accessioned | 2023-06-13T20:34:06Z | |
dc.date.available | 2023-06-13T20:34:06Z | |
dc.date.issued | 2022-06-13 | |
dc.identifier.citation | Frankowski, K. J., Patnaik, S., Wang, C., Southall, N., Dutta, D., De, S., Li, D., Dextras, C., Lin, Y. H., Bryant-Connah, M., Davis, D., Wang, F., Wachsmuth, L. M., Shah, P., Williams, J., Kabir, M., Zhu, E., Baljinnyam, B., Wang, A., Xu, X., … Marugan, J. J. (2022). Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis. Journal of medicinal chemistry, 65(12), 8303–8331. https://doi.org/10.1021/acs.jmedchem.2c00204 | en_US |
dc.identifier.uri | https://hdl.handle.net/1808/34373 | |
dc.description | This document is the Accepted Manuscript version of a Published Work that appeared in final form in Journal of Medicinal Chemistry, Copyright © 2022 American Chemical Society after peer review and technical editing by the publisher. To access the final edited and published work see https://doi.org/10.1021/acs.jmedchem.2c00204. | en_US |
dc.description.abstract | The perinucleolar compartment (PNC) is a dynamic subnuclear body found at the periphery of the nucleolus. The PNC is enriched with RNA transcripts and RNA-binding proteins, reflecting different states of genome organization. PNC prevalence positively correlates with cancer progression and metastatic capacity, making it a useful marker for metastatic cancer progression. A high-throughput, high-content assay was developed to identify novel small molecules that selectively reduce PNC prevalence in cancer cells. We identified and further optimized a pyrrolopyrimidine series able to reduce PNC prevalence in PC3M cancer cells at submicromolar concentrations without affecting cell viability. Structure–activity relationship exploration of the structural elements necessary for activity resulted in the discovery of several potent compounds. Analysis of in vitro drug-like properties led to the discovery of the bioavailable analogue, metarrestin, which has shown potent antimetastatic activity with improved survival in rodent models and is currently being evaluated in a first-in-human phase 1 clinical trial. | en_US |
dc.publisher | American Chemical Society | en_US |
dc.rights | Copyright © 2022 American Chemical Society | en_US |
dc.subject | Metastasis | en_US |
dc.subject | Perinucleolar compartment | en_US |
dc.subject | PNC | en_US |
dc.subject | Metarrestin | en_US |
dc.subject | NCATS-SM0590 | en_US |
dc.subject | Structure-activity relationship | en_US |
dc.subject | PC3M cells | en_US |
dc.title | Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis | en_US |
dc.type | Article | en_US |
kusw.kuauthor | Frankowski, Kevin J. | |
kusw.kuauthor | Aubé, Jeffrey | |
kusw.kuauthor | Schoenen, Frank J. | |
kusw.kudepartment | KU Specialized Chemistry Center | en_US |
dc.identifier.doi | 10.1021/acs.jmedchem.2c00204 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-4265-7620 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0003-4500-880X | en_US |
dc.identifier.orcid | https://orcid.org/0000-0003-1049-5767 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0001-8590-7338 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-3951-7061 | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-7173-6352 | en_US |
kusw.oaversion | Scholarly/refereed, author accepted manuscript | en_US |
kusw.oapolicy | This item meets KU Open Access policy criteria. | en_US |
dc.identifier.pmid | PMC10024865 | en_US |
dc.rights.accessrights | openAccess | en_US |